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ABSTRACT 
Comparative profile studies on the Activated Partial Thromboplastin Time (APTT) and the Prothrombin 
Time (PT) of Naja naja (Indian cobra), Vipera russelli (Indian Russell’s viper) Echis carinatus (Indian 
saw scaled viper) proving their superior Procoagulant efficacy than the normal platelet poor plasma.  
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INTRODUCTION 
Demonstrative methods for the measurement of blood coagulation time conventionally employed, include 
those measuring the Activated APTT, PT and fibrinogen levels. Alternatively, a thrombotic event may 
also  be  confirmed  by  measuring  the  levels  of  soluble  fibrin  or  fibrin  degradation  products  in 
circulation
1.The  venoms  of  several  species  of  snakes  contain  enzymes  that  convert  the  Zymogen 
Prothrombin into the enzyme thrombin and /or its catalytically active precursor meizothrombin. Both the 
activated products convert fibrinogen into fibrin,  thereby resulting in  plasma coagulation
2.Activated 
partial Thromboplastin time’s (APTT) normal range is approximately 25-35 seconds, the time taken by 
citrated  platelet  poor  plasma  to  clot  in  the  presence  of  optimum  concentration  of  contact  activator, 
phospholipid  (platelet  substitute  /partial  Thromboplastin)  and  calcium.  It  screens  for  all  coagulation 
factors  deficiencies;  except  for  factor  VII.
3  The  Activated  Partial  Thromboplastin  (APTT)  tests  the 
integrity of the intrinsic and the final coagulation pathways. Thromboplastin is a tissue extract containing 
tissue factor and a phospholipid. As the test uses only the phospholipid part as a substitute for the platelet 
membrane in activating factor XII, it is known as partial Thromboplastin. Deficiency of factors XII, XI, 
IX, VII, High molecular weight kininogen (HMWK) or kallikerin will prolong the APTT to accelerate the 
PTT reaction. An activator (Celite-diatomaceous earth, Kaolin) is added and hence the term Activated
4. 
An abnormal APTT is associated with quantitative or qualitative deficiencies in factor XII, XI, IX, VIII, 
and V or X
5.  Abnormal APTT values are obtained in the following conditions like i) Factor deficiencies, 
which may be corrected by the addition of normal plasma. ii) Presence of inhibitors like heparin, lupus 
anticoagulant  (LA),  specific  factor  inhibitors,  fibrinogen  degraded  products  (FDP),  which  cannot  be 
corrected by normal plasma addition. 
  Prothrombin  time  (PT);  The  Prothrombin  time  (PT)  measures  the  integrity  of  the  extrinsic 
pathway and the common coagulation pathway. Deficiencies of factor VII or vitamin K and warfarin 
therapy cause an elevation in the PT .Inactivation of factor II by large doses of heparin also prolong the 
PT.  PT  measures  the  time  taken  by  citrated  platelet  poor  plasma  to  clot  in  presence  of  optimum 
concentration of tissue Thromboplastin and calcium.  The results are expressed as PR Prothrombin ratio 
(Patients/control). PR greater than 1.2 is considered as abnormal. It is very important that in the event of 
an injury or accident or a blood disorder, blood  has to clot in particular time range (The normal clotting 
time  for a healthy  individual  weighing 70kgs  is (5-15minutes ) and therefore, if the clotting time  is 
prolonged, there would be copious loss of blood resulting in the drop of systolic blood pressure, followed 
by circulatory collapse, ultimately resulting in a state of shock and heart failure .Hence, such severe loss 
of blood should be prevented and if  coagulation cannot be brought about due to reasons like genetic 
disorders  like  hemophilic  and  hemorrhagic  syndromes,  circulating  anticoagulants,  thrombocytopenic 
purpuras,  dental  extractions,  prostractomy,  Ophthalmological  surgeries,  gastroenterology,  cosmetic 
surgeries and post delivery bleedings, one must make use of therapeutic external procoagulant support to 
hasten the blood coagulation process
6-7. 
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In the present investigation we have compared the APTT and PT of crude venoms Indian venomous 
snakes with the normal APTT and PT of human platelet poor plasma.                                           
 
MATERIALS AND METHODS 
Crude  venoms  of  Naja  naja  (Indian  cobra),  Vipera  russelli  (Indian  Russell’s  viper),  Echis  carinatus 
(Indian saw scaled viper) were procured from The Irula snake catcher’s society, Chennai, India. Human 
citrated  platelet  poor  plasma  was  procured  from  the  Karnatak  Cancer  Research  Institute  Navnagar 
Hubli.,Test kits  for APTT and PT determination were procured from Tulip Diagnostics (P) LTD. Unit II 
first floor, Plot nos. 92/96,Phase II C, Verna IND. EST. Verna, Goa -403 722,India 
 
Activated Partial Thromboplastin Time (APTT) Determination 
Reagents attained room temperature before prewarming to 37
0C for testing purposes. The kit reagents 
were mixed well by gentle swirling. To a 12x15mm test tube, add 0.1ml crude venom sample and 0.1ml 
liquiceline-E, shake the tube gently to mix.  Next place the tube in an incubator for 3minutes at 37
0C. 
Following incubation, add 0.1ml of prewarmed calcium chloride and simultaneously start the stop watch 
to measure the time of clot formation
8.  
 
Prothrombin Time (PT) Determination 
Reagents were brought to room temperature before prewarming to 37
0C for testing purposes. Kit reagents 
were mixed well. To a 12x15mm tube add0.1ml of crude snake venom which was incubated for 3minutes 
at  37
0C.Next  add  0.2ml  of  liquiplastin  reagent  (prewarmed  at  37
0C  for  at  least  3minutes)  and 
simultaneously start the stop watch and note the time of appearance of first fibrin strand
9-10. 
 
RESULT 
Comparative APTT and PT of the crude venoms of Naja naja, Vipera russelli and Echis carinatus proving 
their superior procoagulant efficacy is shown in the table 1. 
 
DISCUSSION 
Indian  venomous  snakes,  Echis  carinatus  and  Naja  naja  take  about  13  times  less  time  for    the  clot 
formation, where as Vipera russelli crude venom takes about 2.23 times less time  for clot formation, as 
their APTT and PT times  are far less than the  normal platelet poor human plasma. Hence, one could Gadag J R et al / IJRAP 2010, 1 (2) 586-589 
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make  use  of  these  venoms  in  the  treatment  of  coagulation  disorders,  thus  proving  their  superior 
Procoagulant efficacy over the existing commercial pharmaceutical preparations
11.  
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Table 1: The time taken for the APTT and PT by the different snake venoms 
  
Samples  APTT (Time in seconds)  PT (Time in seconds) 
Normal platelet poor human plasma  35  5.62 
Vipera russelli crude venom  15.66  4.32 
Echis carinatus crude venom  2.65  2.57 
Naja naja crude venom  2.65  2.53 
 